These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 29867083)

  • 1. Luteolin attenuates Wnt signaling via upregulation of FZD6 to suppress prostate cancer stemness revealed by comparative proteomics.
    Han K; Lang T; Zhang Z; Zhang Y; Sun Y; Shen Z; Beuerman RW; Zhou L; Min D
    Sci Rep; 2018 Jun; 8(1):8537. PubMed ID: 29867083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The flavonoid luteolin suppresses infantile hemangioma by targeting FZD6 in the Wnt pathway.
    Dai Y; Zheng H; Liu Z; Wang Y; Hu W
    Invest New Drugs; 2021 Jun; 39(3):775-784. PubMed ID: 33411210
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Luteolin inhibits colorectal cancer cell epithelial-to-mesenchymal transition by suppressing CREB1 expression revealed by comparative proteomics study.
    Liu Y; Lang T; Jin B; Chen F; Zhang Y; Beuerman RW; Zhou L; Zhang Z
    J Proteomics; 2017 May; 161():1-10. PubMed ID: 28391045
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Upregulation of prostate-derived Ets factor by luteolin causes inhibition of cell proliferation and cell invasion in prostate carcinoma cells.
    Tsui KH; Chung LC; Feng TH; Chang PL; Juang HH
    Int J Cancer; 2012 Jun; 130(12):2812-23. PubMed ID: 21780100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ASPM promotes prostate cancer stemness and progression by augmenting Wnt-Dvl-3-β-catenin signaling.
    Pai VC; Hsu CC; Chan TS; Liao WY; Chuu CP; Chen WY; Li CR; Lin CY; Huang SP; Chen LT; Tsai KK
    Oncogene; 2019 Feb; 38(8):1340-1353. PubMed ID: 30266990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frizzled7 Promotes Epithelial-to-mesenchymal Transition and Stemness Via Activating Canonical Wnt/β-catenin Pathway in Gastric Cancer.
    Li G; Su Q; Liu H; Wang D; Zhang W; Lu Z; Chen Y; Huang X; Li W; Zhang C; He Y; Fu L; Bi J
    Int J Biol Sci; 2018; 14(3):280-293. PubMed ID: 29559846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-320 suppresses the stem cell-like characteristics of prostate cancer cells by downregulating the Wnt/beta-catenin signaling pathway.
    Hsieh IS; Chang KC; Tsai YT; Ke JY; Lu PJ; Lee KH; Yeh SD; Hong TM; Chen YL
    Carcinogenesis; 2013 Mar; 34(3):530-8. PubMed ID: 23188675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Luteolin directly binds to KDM4C and attenuates ovarian cancer stemness via epigenetic suppression of PPP2CA/YAP axis.
    Li Y; Hu Y; Yang L; Liu J; Cui C; Yang M; Zou D; Zhou L; Zhou Q; Ge W; Lang T
    Biomed Pharmacother; 2023 Apr; 160():114350. PubMed ID: 36804120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-7 inhibits the stemness of prostate cancer stem-like cells and tumorigenesis by repressing KLF4/PI3K/Akt/p21 pathway.
    Chang YL; Zhou PJ; Wei L; Li W; Ji Z; Fang YX; Gao WQ
    Oncotarget; 2015 Sep; 6(27):24017-31. PubMed ID: 26172296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Let7b modulates the Wnt/β-catenin pathway in liver cancer cells via downregulated Frizzled4.
    Cai H; Chen Y; Yang X; Ma S; Wang Q; Zhang Y; Niu X; Ding G; Yuan Y
    Tumour Biol; 2017 Jul; 39(7):1010428317716076. PubMed ID: 28671046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SOX8 regulates cancer stem-like properties and cisplatin-induced EMT in tongue squamous cell carcinoma by acting on the Wnt/β-catenin pathway.
    Xie SL; Fan S; Zhang SY; Chen WX; Li QX; Pan GK; Zhang HQ; Wang WW; Weng B; Zhang Z; Li JS; Lin ZY
    Int J Cancer; 2018 Mar; 142(6):1252-1265. PubMed ID: 29071717
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wild-type p53 suppresses the epithelial-mesenchymal transition and stemness in PC-3 prostate cancer cells by modulating miR‑145.
    Ren D; Wang M; Guo W; Zhao X; Tu X; Huang S; Zou X; Peng X
    Int J Oncol; 2013 Apr; 42(4):1473-81. PubMed ID: 23404342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltrating bone marrow mesenchymal stem cells increase prostate cancer stem cell population and metastatic ability via secreting cytokines to suppress androgen receptor signaling.
    Luo J; Ok Lee S; Liang L; Huang CK; Li L; Wen S; Chang C
    Oncogene; 2014 May; 33(21):2768-78. PubMed ID: 23792449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CAPE suppresses migration and invasion of prostate cancer cells via activation of non-canonical Wnt signaling.
    Tseng JC; Lin CY; Su LC; Fu HH; Yang SD; Chuu CP
    Oncotarget; 2016 Jun; 7(25):38010-38024. PubMed ID: 27191743
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of cell cycle and RNA transcription genes identified by microarray analysis of PC-3 human prostate cancer cells treated with luteolin.
    Shoulars K; Rodriguez MA; Thompson T; Markaverich BM
    J Steroid Biochem Mol Biol; 2010 Jan; 118(1-2):41-50. PubMed ID: 19837161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FZD6 expression is negatively regulated by miR-199a-5p in human colorectal cancer.
    Kim BK; Yoo HI; Kim I; Park J; Kim Yoon S
    BMB Rep; 2015 Jun; 48(6):360-6. PubMed ID: 25772759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FZD4 as a mediator of ERG oncogene-induced WNT signaling and epithelial-to-mesenchymal transition in human prostate cancer cells.
    Gupta S; Iljin K; Sara H; Mpindi JP; Mirtti T; Vainio P; Rantala J; Alanen K; Nees M; Kallioniemi O
    Cancer Res; 2010 Sep; 70(17):6735-45. PubMed ID: 20713528
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Luteolin induces apoptosis via death receptor 5 upregulation in human malignant tumor cells.
    Horinaka M; Yoshida T; Shiraishi T; Nakata S; Wakada M; Nakanishi R; Nishino H; Matsui H; Sakai T
    Oncogene; 2005 Nov; 24(48):7180-9. PubMed ID: 16007131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of microRNA-454 impedes the proliferation and invasion of prostate cancer cells by promoting N-myc downstream-regulated gene 2 and inhibiting WNT/β-catenin signaling.
    Fu Q; Gao Y; Yang F; Mao T; Sun Z; Wang H; Song B; Li X
    Biomed Pharmacother; 2018 Jan; 97():120-127. PubMed ID: 29080452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BTF3 sustains cancer stem-like phenotype of prostate cancer via stabilization of BMI1.
    Hu J; Sun F; Chen W; Zhang J; Zhang T; Qi M; Feng T; Liu H; Li X; Xing Y; Xiong X; Shi B; Zhou G; Han B
    J Exp Clin Cancer Res; 2019 May; 38(1):227. PubMed ID: 31138311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.